NOS2 and hypertensive disorder: In 2008, Nakata et al. [75] demonstrated NOS isoforms knockout mice in conditions of hypertension, hyperlipidemia, impaired glucose tolerance, insulin resistance, metabolic syndrome and presence of visceral obesity.